AUTOLOGOUS STEM CELL MOBILISATION AND -TRANSPLANTATION IN PAEDIATRIC ONCOLOGY; POOR MOBILIZERS, PLERIXAFOR AND PEGFILGRASTIM

被引:0
|
作者
Hochheuser, Caroline [1 ,2 ]
Rozeman, Maria [1 ]
Kunze, Nina [2 ]
Gelineau, Nina [1 ,3 ]
Kuijk, Carlijn [2 ]
Jaspers-Bakkers, Antoinette [1 ]
Van Den Bos, Cor [4 ]
Slager, Tirza [5 ]
Zsiros, Jozsef [1 ]
Tissing, Wim [6 ,7 ]
Westinga, Kasper [8 ]
Zwaan, C. Michel
Voermans, Carlijn [2 ]
Tytgat, Lieve [1 ]
Kraal, K. C. J. M. [1 ]
Timmerman, Ilse [1 ,2 ]
机构
[1] Prinses Maxima Centrum, Solid Tumors, Utrecht, Netherlands
[2] Univ Amsterdam, Dept Hematopoiesis, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Expt Immunohematol, Acad Med Ctr Amsterdam, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands
[4] Prinses Maxima Ctr Pediat Oncol, Haematooncol, Utrecht, Netherlands
[5] Erasmus MC, Rotterdam, Netherlands
[6] Princess Maxima Ctr Pediat Oncol, Support Care, Utrecht, Netherlands
[7] Univ Med Ctr Groningen, Dept Pediat Oncol Hematol, Groningen, Netherlands
[8] Univ Med Ctr Utrecht, Dept Clin Pharm, Cell Therapy Facil, Utrecht, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O296
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Autologous Stem Cell Transplantation in Paediatric Oncology; Poor Mobilizers, Plerixafor and Pegfilgrastim
    Timmerman, I.
    Rozeman, M. L.
    Japsers-Bakker, A.
    Van den Bos, C.
    Zsiros, J.
    Tissing, W.
    Westinga, K.
    Voermans, C.
    Zwaan, C. M.
    Tytgat, L.
    Kraal, K. C. J. M.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S214 - S215
  • [2] Stem cell mobilisation for autologous transplantation: outcomes and rationalising the indications for using plerixafor
    Williams, M.
    Donaghey, S.
    Angelica, R.
    Woolley, J.
    Bloor, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S237 - S237
  • [3] Hope for poor stem cell mobilizers? Our experience with plerixafor
    Baker, J.
    Brennan, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S340 - S340
  • [4] Second Autologous Stem Cell Transplantation in Poor Stem Cell Mobilizers Multiple Myeloma Patients
    Sever, Matjaz
    Sbianchi, Giulia
    Iacobelli, Simona
    van der Werf, Steffie
    Wieslaw, Wiktor-Jedrzejczak
    Blaise, Didier
    Apperley, Jane F.
    Mohty, Mohamad
    Scheid, Christof
    Wilson, Keith
    Russel, Nigel H.
    Kalhs, Peter
    Chevallier, Patrice
    Ringhoffer, Mark
    Kobbe, Guido
    Mayer, Jiri
    Jost, Edgar
    Zudaire, Teresa
    Schiel, Xaver
    Isaksson, Cecilia
    Trneny, Marek
    Schonland, Stefan
    Morris, Curly
    Garderet, Laurent
    Kroeger, Nicolaus
    BLOOD, 2017, 130
  • [5] Mozobil (plerixafor) - decision for "poor mobilisers" in autologous stem cell transplantation
    Arnaudov, G.
    Ganeva, P.
    MIncheff, M.
    Tonev, I.
    Guenova, M.
    Mihaylov, G.
    Toshkov, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S238 - S238
  • [6] Plerixafor significantly increases the hematopoietic stem cell yield in documented poor mobilizers in the autologous and allogeneic setting
    Haen, S. P.
    Schober-Melms, I
    Bethge, W. A.
    Moehle, R.
    Schumm, M.
    Kanz, L.
    Vogel, W.
    ONKOLOGIE, 2013, 36 : 133 - 133
  • [7] PLERIXAFOR IN POOR STEM CELL MOBILIZERS: THE BELGIAN COMPASSIONATE USE PROGRAM
    Selleslag, D.
    Dierickx, D.
    Breems, D. A.
    Huynh, P.
    Van De Velde, A.
    Meers, S.
    Brouwer, E.
    Mertens, A.
    ACTA CLINICA BELGICA, 2011, 66 (03) : 200 - 204
  • [8] Autologous Stem Cell Mobilization with Pegfilgrastim and Planned Plerixafor Is Equally Effective and Safer As Compared with Cyclophosphamide, Pegfilgrastim and Plerixafor
    Tuazon, Sherilyn
    Sharma, Manish
    Zhan, Tingting
    Kasner, Margaret
    Alpdogan, Onder
    Martinez, Ubaldo
    Grosso, Dolores
    Filicko, Joanne
    Pro, Barbara
    Wagner, John L.
    Carabasi, Matthew
    Flomenberg, Neal
    Weiss, Mark
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S119 - S119
  • [9] HIGH DOSE PLERIXAFOR AND LARGE VOLUME LEUKAPHERESIS - IS IT THE ANSWER FOR AUTOLOGOUS STEM CELL TRANSPLANTS IN ABSOLUTE POOR MOBILIZERS?
    Jain, Amit
    Sharma, Ratna
    Patil, Rajesh
    Mehta, Nidhi
    Kini, Pranoti
    Walawalkar, Ashutosh
    Srivastava, Srishti
    Manglani, Mamta
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 614 - 614
  • [10] How to manage poor mobilizers for high dose chemotherapy and autologous stem cell transplantation?
    Atilla, Pinar Ataca
    Ozturk, Sule Mine Bakanay
    Demirer, Taner
    TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (02) : 190 - 198